Table 4

 Standardised incidence ratios* (SIRs) for various cancers for employees with potential alachlor exposure (workplace or drinking water)

Type of cancerAny alachlor exposureHigh alachlor exposure5+ years high exposure 15+ years since first exposure
O/E†SIR95% CIO/E†SIR95% CIO/E†SIR95% CI
*SIRs and 95% CIs were not calculated unless observed or expected cases exceeded 1.
†Observed number of cases/expected number of cases.
All cancers36/28.312789 to 17629/23.412382 to 1778/7.111349 to 224
Buccal cavity2/1.414417 to 5202/1.216320 to 5900/0.5
Digestive8/5.614261 to 2796/4.912245 to 2652/1.910813 to 389
    Colon4/2.416946 to 4344/2.119453 to 4972/0.825631 to 925
    Rectum2/1.316019 to 5800/1.100 to 2240/0.4
    Liver, gall bladder1/0.41/0.30/0.1
    Pancreas1/0.61/0.60/0.2
Lung2/4.5455 to 1622/4.0506 to 1811/1.7592 to 327
Melanoma6/2.2278102 to 6064/1.822962 to 5870/0.4
Breast2/2.8719 to 2552/2.010112 to 3630/0.3
Female genital2/1.513617 to 4921/1.00/0.2
Prostate4/3.511531 to 2954/3.212534 to 3192/1.712015 to 434
Testis3/1.323549 to 6861/1.00/0.1
Kidney1/1.1942 to 5261/0.91/0.4
Non-Hodgkin’s lymphoma3/1.717336 to 5043/1.520743 to 6041/0.5
Hodgkin’s disease1/0.71/0.50/0.1
Leukaemia2/1.117621 to 6362/1.020625 to 7440/0.3
    Chronic myeloid leukaemia2/0.2955116 to 34482/0.171165141 to 42100/0.04